InsidersTradesSigma
Track the Arbutus Biopharma Corporation share price and the full directors' dealings record of the company, a listed equity based in Canada. Shares are listed on the CA market, under the authority of SEDI. Market capitalisation: €985.3m. The latest transaction was reported on 11 June 2026 (50 - Grant of options). Among the most active insiders: Sawhney, Roger. Every trade is free.
Analysts rate Arbutus Biopharma Corporation Strong Buy (bullish), based on 1 analysts. Average price target: US$5.53.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Arbutus Biopharma Corporation 是一家生物制药公司，专注于开发病毒感染（特别是乙型肝炎）的治疗方法。该公司在多伦多证券交易所上市，股票代码为 ABUS。